首页> 美国卫生研究院文献>Oxidative Medicine and Cellular Longevity >Transplantation of Bone Marrow Mesenchymal Stem Cells Prevents Radiation-Induced Artery Injury by Suppressing Oxidative Stress and Inflammation
【2h】

Transplantation of Bone Marrow Mesenchymal Stem Cells Prevents Radiation-Induced Artery Injury by Suppressing Oxidative Stress and Inflammation

机译:骨髓间充质干细胞的移植通过抑制氧化应激和炎症反应来预防辐射诱发的动脉损伤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study aims to explore the protective effect of human bone marrow mesenchymal stem cells (hBMSCs) on radiation-induced aortic injury (RIAI). hBMSCs were isolated and cultured from human bone marrow. Male C57/BL mice were irradiated with a dose of 18-Gy 6MV X-ray and randomly treated with either vehicle or hBMSCs through tail vein injection with a dose of 103 or 104 cells/g of body weight (low or high dose of hBMSCs) within 24 h. Aortic inflammation, oxidative stress, and vascular remodeling were assessed by immunohistochemical staining at 3, 7, 14, 28, and 84 days after irradiation. The results revealed irradiation caused aortic cell apoptosis and fibrotic remodeling indicated by aortic thickening, collagen accumulation, and increased expression of profibrotic cytokines (CTGF and TGF-β). Further investigation showed that irradiation resulted in elevated expression of inflammation-related molecules (TNF-α and ICAM-1) and oxidative stress indicators (4-HNE and 3-NT). Both of the low and high doses of hBMSCs alleviated the above irradiation-induced pathological changes and elevated the antioxidant enzyme expression of HO-1 and catalase in the aorta. The high dose even showed a better protective effect. In conclusion, hBMSCs provide significant protection against RIAI possibly through inhibition of aortic oxidative stress and inflammation. Therefore, hBMSCs can be used as a potential therapy to treat RIAI.
机译:本研究旨在探讨人骨髓间充质干细胞(hBMSCs)对放射诱发的主动脉损伤(RIAI)的保护作用。从人骨髓中分离并培养了hBMSC。雄性C57 / BL小鼠接受18-Gy 6MV X射线照射,并通过尾静脉注射10 3 或10 4 < / sup>细胞/ g体重(低剂量或高剂量的hBMSC)在24小时内。在照射后3、7、14、28和84天通过免疫组织化学染色评估主动脉炎症,氧化应激和血管重塑。结果表明,辐照导致主动脉增厚,胶原蛋白积聚和原纤维化细胞因子(CTGF和TGF-β)表达增加,提示主动脉细胞凋亡和纤维化重塑。进一步的研究表明,辐射导致炎症相关分子(TNF-α和ICAM-1)和氧化应激指标(4-HNE和3-NT)的表达升高。低剂量和高剂量的hBMSC均可缓解上述辐射诱发的病理变化,并提高主动脉中HO-1和过氧化氢酶的抗氧化酶表达。高剂量甚至显示出更好的保护作用。总之,hBMSC可能通过抑制主动脉氧化应激和炎症而提供了针对RIAI的重要保护。因此,hBMSCs可用作治疗RIAI的潜在疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号